Teva Gets FDA Approval for Generic ADHD Drug
From Associated Press (February 14, 2013)
NEW YORK -- Teva Pharmaceutical Industries Ltd. said Thursday
that it received marketing approval for a generic version of Shire
PLC’s Adderall XR, a treatment for attention deficit
hyperactivity...
Source: Drugs.com - Pharma News - Category: Pharmaceuticals Source Type: news